Publication:
Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?

dc.contributor.authorsKilickap, S.; Basal, F. Bugdayci; Demirkazik, A.; Gursoy, P.; Demirci, U.; Erman, M.; Yumuk, F.; Senler, F. Cay; Cakar, B.; Cicin, I.; Ozturk, A.; Coskun, H. S.; Cubukcu, E.; Isikdogan, A.; Olmez, O. F.; Tatli, A. M.; Karaagac, M.; Sakalar, T.; Eralp, Y.; Korkmaz, T.
dc.date.accessioned2022-03-12T16:24:30Z
dc.date.accessioned2026-01-10T16:57:05Z
dc.date.available2022-03-12T16:24:30Z
dc.date.issued2019
dc.identifier.doidoiWOS:000491295504209
dc.identifier.eissn1569-8041
dc.identifier.issn0923-7534
dc.identifier.urihttps://hdl.handle.net/11424/226362
dc.identifier.wosWOS:000491295504209
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.ispartofANNALS OF ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleIs there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage637
oaire.citation.startPage637
oaire.citation.titleANNALS OF ONCOLOGY
oaire.citation.volume30

Files